73 related articles for article (PubMed ID: 28645563)
1. Bruceine D inhibits hepatocellular carcinoma growth by targeting β-catenin/jagged1 pathways.
Cheng Z; Yuan X; Qu Y; Li X; Wu G; Li C; Zu X; Yang N; Ke X; Zhou J; Xie N; Xu X; Liu S; Shen Y; Li H; Zhang W
Cancer Lett; 2017 Sep; 403():195-205. PubMed ID: 28645563
[TBL] [Abstract][Full Text] [Related]
2. Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway.
Liu Y; Zhuang H; Cao F; Li J; Guo Y; Zhang J; Zhao Q; Liu Y
Cell Death Dis; 2021 Mar; 12(3):278. PubMed ID: 33723262
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative Effects of Epigenetic Modifier Drugs Through E-cadherin Up-regulation in Liver Cancer Cell Lines.
Uribe D; Cardona A; Esposti DD; Cros MP; Cuenin C; Herceg Z; Camargo M; Cortés-Mancera FM
Ann Hepatol; 2018; 17(3):444-460. PubMed ID: 29735783
[TBL] [Abstract][Full Text] [Related]
4. Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling.
Soong RS; Anchoori RK; Roden RBS; Cho RL; Chen YC; Tseng SC; Huang YL; Liao PC; Shyu YC
BMC Cancer; 2020 May; 20(1):386. PubMed ID: 32375699
[TBL] [Abstract][Full Text] [Related]
5. USP3 inhibition is Active Against Chemo-resistant Hepatocellular Carcinoma Anchorage-independent Growth
Xu J; Gui GSW; Yang C; Zhu S; Chen Z; Ma SLB; Yang C; Bu CRL; Zhu Y; Xu W
Curr Mol Med; 2024; 24(5):667-675. PubMed ID: 37921189
[TBL] [Abstract][Full Text] [Related]
6. RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular carcinoma via the Wnt/β-catenin-ferroptosis axis.
Li Z; Caron de Fromentel C; Kim W; Wang WH; Sun J; Yan B; Utturkar S; Lanman NA; Elzey BD; Yeo Y; Zhang H; Kazemian M; Levrero M; Andrisani O
Cell Death Dis; 2023 Nov; 14(11):786. PubMed ID: 38036507
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of Codonopsis pilosula in inhibiting hepatocellular carcinoma growth and metastasis.
Li N; Yang C; Xia J; Wang W; Xiong W
Phytomedicine; 2024 Jun; 128():155338. PubMed ID: 38520835
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535.
Gedaly R; Galuppo R; Daily MF; Shah M; Maynard E; Chen C; Zhang X; Esser KA; Cohen DA; Evers BM; Jiang J; Spear BT
PLoS One; 2014; 9(6):e99272. PubMed ID: 24940873
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.
Zheng Q; Lin Z; Xu J; Lu Y; Meng Q; Wang C; Yang Y; Xin X; Li X; Pu H; Gui X; Li T; Xiong W; Lu D
Cell Death Dis; 2018 Feb; 9(3):253. PubMed ID: 29449541
[TBL] [Abstract][Full Text] [Related]
10. β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma.
Wang Y; Cheng C; Lu Y; Lian Z; Liu Q; Xu Y; Li Y; Li H; Zhang L; Jiang X; Li B; Yu D
Cancer Res; 2024 May; 84(10):1643-1658. PubMed ID: 38417136
[TBL] [Abstract][Full Text] [Related]
11. The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk.
Xu C; Gao X; Ren T; Geng H; Yang K; Huang Y; Zhang W; Hou S; Song A; Zhang Y; Zhao Q
Pharmacol Res; 2024 May; 203():107142. PubMed ID: 38522759
[TBL] [Abstract][Full Text] [Related]
12. Gallic acid promotes ferroptosis in hepatocellular carcinoma via inactivating Wnt/β-catenin signaling pathway.
Xie J; Wang H; Xie W; Liu Y; Chen Y
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2437-2445. PubMed ID: 37847411
[TBL] [Abstract][Full Text] [Related]
13. Carnosic acid nanocluster-based framework combined with PD-1 inhibitors impeded tumorigenesis and enhanced immunotherapy in hepatocellular carcinoma.
Wu W; Li Y; Wu X; Liang J; You W; He X; Feng Q; Li T; Jia X
Funct Integr Genomics; 2024 Jan; 24(1):5. PubMed ID: 38182693
[TBL] [Abstract][Full Text] [Related]
14. Targeting Trop2 by Bruceine D suppresses breast cancer metastasis by blocking Trop2/β-catenin positive feedback loop.
Tang W; Hu Y; Tu K; Gong Z; Zhu M; Yang T; Sarwar A; Dai B; Zhang D; Zhan Y; Zhang Y
J Adv Res; 2024 Apr; 58():193-210. PubMed ID: 37271476
[TBL] [Abstract][Full Text] [Related]
15. WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma.
Rialdi A; Duffy M; Scopton AP; Fonseca F; Zhao JN; Schwarz M; Molina-Sanchez P; Mzoughi S; Arceci E; Abril-Fornaguera J; Meadows A; Ruiz de Galarreta M; Torre D; Reyes K; Lim YT; Rosemann F; Khan ZM; Mohammed K; Wang X; Yu X; Lakshmanan M; Rajarethinam R; Tan SY; Jin J; Villanueva A; Michailidis E; De Jong YP; Rice CM; Marazzi I; Hasson D; Llovet JM; Sobota RM; Lujambio A; Guccione E; Dar AC
Nat Cancer; 2023 Aug; 4(8):1157-1175. PubMed ID: 37537299
[TBL] [Abstract][Full Text] [Related]
16. Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS/MAPK signaling pathway in vitro and in vivo.
Fan J; Ren D; Wang J; Liu X; Zhang H; Wu M; Yang G
Cell Death Dis; 2020 Feb; 11(2):126. PubMed ID: 32071301
[TBL] [Abstract][Full Text] [Related]
17. Bruceine D inhibits tumor growth and stem cell-like traits of osteosarcoma through inhibition of STAT3 signaling pathway.
Wang S; Hu H; Zhong B; Shi D; Qing X; Cheng C; Deng X; Zhang Z; Shao Z
Cancer Med; 2019 Dec; 8(17):7345-7358. PubMed ID: 31631559
[TBL] [Abstract][Full Text] [Related]
18. Bruceine D induces apoptosis in human non-small cell lung cancer cells through regulating JNK pathway.
Tan B; Huang Y; Lan L; Zhang B; Ye L; Yan W; Wang F; Lin N
Biomed Pharmacother; 2019 Sep; 117():109089. PubMed ID: 31226632
[TBL] [Abstract][Full Text] [Related]
19. Bruceine D Isolated from Brucea Javanica (L.) Merr. as a Systemic Feeding Deterrent for Three Major Lepidopteran Pests.
Mao G; Tian Y; Sun Z; Ou J; Xu H
J Agric Food Chem; 2019 Apr; 67(15):4232-4239. PubMed ID: 30901209
[TBL] [Abstract][Full Text] [Related]
20. Brucea javanica: A review on anticancer of its pharmacological properties and clinical researches.
Li KW; Liang YY; Wang Q; Li Y; Zhou SJ; Wei HC; Zhou CZ; Wan XH
Phytomedicine; 2021 Jun; 86():153560. PubMed ID: 33858739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
